vs
ASGN Inc（ASGN）与GE医疗（CCRN）财务数据对比。点击上方公司名可切换其他公司
ASGN Inc的季度营收约是GE医疗的4.1倍（$970.0M vs $236.8M）。ASGN Inc净利率更高（0.6% vs -35.0%，领先35.6%）。ASGN Inc同比增速更快（-3.0% vs -23.6%）。GE医疗自由现金流更多（$16.1M vs $9.1M）。过去两年ASGN Inc的营收复合增速更高（-3.2% vs -21.0%）
ASGN Inc是总部位于美国的领先专业服务与人力资源解决方案供应商，主营信息技术、创意设计、生命科学、工程等领域的技术人才供给及咨询服务，主要服务北美地区的企业级客户。
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
ASGN vs CCRN — 直观对比
营收规模更大
ASGN
是对方的4.1倍
$236.8M
营收增速更快
ASGN
高出20.6%
-23.6%
净利率更高
ASGN
高出35.6%
-35.0%
自由现金流更多
CCRN
多$7.0M
$9.1M
两年增速更快
ASGN
近两年复合增速
-21.0%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $970.0M | $236.8M |
| 净利润 | $5.5M | $-82.9M |
| 毛利率 | 27.5% | — |
| 营业利润率 | 2.9% | -30.2% |
| 净利率 | 0.6% | -35.0% |
| 营收同比 | -3.0% | -23.6% |
| 净利润同比 | -73.7% | -2109.7% |
| 每股收益（稀释后） | $0.13 | $-2.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASGNCCRN
| Q1 26 | $970.0M | — | ||
| Q4 25 | $980.1M | $236.8M | ||
| Q3 25 | $1.0B | $250.1M | ||
| Q2 25 | $1.0B | $274.1M | ||
| Q1 25 | $968.3M | $293.4M | ||
| Q4 24 | $985.0M | $309.9M | ||
| Q3 24 | $1.0B | $315.1M | ||
| Q2 24 | $1.0B | $339.8M |
净利润ASGNCCRN
| Q1 26 | $5.5M | — | ||
| Q4 25 | $25.2M | $-82.9M | ||
| Q3 25 | $38.1M | $-4.8M | ||
| Q2 25 | $29.3M | $-6.7M | ||
| Q1 25 | $20.9M | $-490.0K | ||
| Q4 24 | $42.4M | $-3.8M | ||
| Q3 24 | $47.5M | $2.6M | ||
| Q2 24 | $47.2M | $-16.1M |
毛利率ASGNCCRN
| Q1 26 | 27.5% | — | ||
| Q4 25 | 28.9% | — | ||
| Q3 25 | 29.4% | 20.4% | ||
| Q2 25 | 28.7% | 20.4% | ||
| Q1 25 | 28.4% | 20.0% | ||
| Q4 24 | 29.0% | — | ||
| Q3 24 | 29.1% | 20.4% | ||
| Q2 24 | 29.1% | 20.8% |
营业利润率ASGNCCRN
| Q1 26 | 2.9% | — | ||
| Q4 25 | 5.7% | -30.2% | ||
| Q3 25 | 6.7% | -2.4% | ||
| Q2 25 | 5.8% | -2.1% | ||
| Q1 25 | 4.8% | -0.3% | ||
| Q4 24 | 7.5% | -1.1% | ||
| Q3 24 | 7.7% | 0.9% | ||
| Q2 24 | 7.8% | -5.7% |
净利率ASGNCCRN
| Q1 26 | 0.6% | — | ||
| Q4 25 | 2.6% | -35.0% | ||
| Q3 25 | 3.8% | -1.9% | ||
| Q2 25 | 2.9% | -2.4% | ||
| Q1 25 | 2.2% | -0.2% | ||
| Q4 24 | 4.3% | -1.2% | ||
| Q3 24 | 4.6% | 0.8% | ||
| Q2 24 | 4.6% | -4.7% |
每股收益（稀释后）ASGNCCRN
| Q1 26 | $0.13 | — | ||
| Q4 25 | $0.58 | $-2.56 | ||
| Q3 25 | $0.87 | $-0.15 | ||
| Q2 25 | $0.67 | $-0.20 | ||
| Q1 25 | $0.48 | $-0.02 | ||
| Q4 24 | $0.94 | $-0.13 | ||
| Q3 24 | $1.06 | $0.08 | ||
| Q2 24 | $1.02 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $143.6M | $108.7M |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $1.8B | $322.8M |
| 总资产 | $4.0B | $449.0M |
| 负债/权益比越低杠杆越低 | 0.82× | — |
8季度趋势，按日历期对齐
现金及短期投资ASGNCCRN
| Q1 26 | $143.6M | — | ||
| Q4 25 | $161.2M | $108.7M | ||
| Q3 25 | — | $99.1M | ||
| Q2 25 | — | $81.2M | ||
| Q1 25 | — | $80.7M | ||
| Q4 24 | $205.2M | $81.6M | ||
| Q3 24 | — | $64.0M | ||
| Q2 24 | — | $69.6M |
总债务ASGNCCRN
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.0B | — |
股东权益ASGNCCRN
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $322.8M | ||
| Q3 25 | $1.8B | $408.1M | ||
| Q2 25 | $1.8B | $412.2M | ||
| Q1 25 | $1.8B | $418.2M | ||
| Q4 24 | $1.8B | $419.0M | ||
| Q3 24 | $1.8B | $424.7M | ||
| Q2 24 | $1.8B | $433.3M |
总资产ASGNCCRN
| Q1 26 | $4.0B | — | ||
| Q4 25 | $3.7B | $449.0M | ||
| Q3 25 | $3.7B | $538.2M | ||
| Q2 25 | $3.7B | $553.8M | ||
| Q1 25 | $3.7B | $576.2M | ||
| Q4 24 | $3.4B | $589.3M | ||
| Q3 24 | $3.4B | $597.4M | ||
| Q2 24 | $3.5B | $602.9M |
负债/权益比ASGNCCRN
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.65× | — | ||
| Q3 25 | 0.64× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.57× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $18.2M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $16.1M |
| 自由现金流率自由现金流/营收 | 0.9% | 6.8% |
| 资本支出强度资本支出/营收 | 1.0% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $290.6M | $40.1M |
8季度趋势，按日历期对齐
经营现金流ASGNCCRN
| Q1 26 | — | — | ||
| Q4 25 | $102.3M | $18.2M | ||
| Q3 25 | $83.9M | $20.1M | ||
| Q2 25 | $124.9M | $4.2M | ||
| Q1 25 | $16.8M | $5.7M | ||
| Q4 24 | $100.2M | $24.2M | ||
| Q3 24 | $135.8M | $7.5M | ||
| Q2 24 | $90.7M | $82.4M |
自由现金流ASGNCCRN
| Q1 26 | $9.1M | — | ||
| Q4 25 | $93.7M | $16.1M | ||
| Q3 25 | $72.0M | $17.9M | ||
| Q2 25 | $115.8M | $2.3M | ||
| Q1 25 | $6.6M | $3.8M | ||
| Q4 24 | $88.9M | $21.7M | ||
| Q3 24 | $127.9M | $6.3M | ||
| Q2 24 | $85.4M | $79.6M |
自由现金流率ASGNCCRN
| Q1 26 | 0.9% | — | ||
| Q4 25 | 9.6% | 6.8% | ||
| Q3 25 | 7.1% | 7.2% | ||
| Q2 25 | 11.3% | 0.8% | ||
| Q1 25 | 0.7% | 1.3% | ||
| Q4 24 | 9.0% | 7.0% | ||
| Q3 24 | 12.4% | 2.0% | ||
| Q2 24 | 8.3% | 23.4% |
资本支出强度ASGNCCRN
| Q1 26 | 1.0% | — | ||
| Q4 25 | 0.9% | 0.9% | ||
| Q3 25 | 1.2% | 0.9% | ||
| Q2 25 | 0.9% | 0.7% | ||
| Q1 25 | 1.1% | 0.6% | ||
| Q4 24 | 1.1% | 0.8% | ||
| Q3 24 | 0.8% | 0.4% | ||
| Q2 24 | 0.5% | 0.8% |
现金转化率ASGNCCRN
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | — | ||
| Q3 25 | 2.20× | — | ||
| Q2 25 | 4.26× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 2.36× | — | ||
| Q3 24 | 2.86× | 2.92× | ||
| Q2 24 | 1.92× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASGN
暂无分部数据
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
